Presently, we are covering analysis for 1000+ stocks for which we have sufficient data to perform the fundamental and valuation analysis and whose Market cap is more than 100 Cr.

The list of all covered stocks can be seen here.
You are here : Home / All Sectors / Healthcare / Pharmaceuticals / CAPLIN POINT LABORATORIES LTD

CAPLIN POINT LABORATORIES Analysis

Returns | 1W : -2.8% , 1M : 6.4%,1Y : 29.9%
BSE : 524742     NSE : CAPLIPOINT   
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
The long term FVD (Fundamentals - Valuation - Debt) Squares represent long term view for a company based on Annual Earnings, Valuation and Debt of the stock. This summary is suitable for Investors investing in the market with a time horizon of more than 3 years.

Good
Average
Bad
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
  
The short term QPP (Quarterly Earnings Trend- Price Momentum - Pledged Shares) Squares represent short term view for a company which is suitable for Traders taking positions in the market with a time horizon of less than 3 years .

Good
Average
Bad
Sep 24,2020
Price(EOD): Rs. 539.00
This is the End-of-Day (EOD) Stock Price updated daily by 10 pm IST.
Industry : Pharmaceuticals
MarketCap: Rs. 4,074.84 Cr
Stock Market Investing Simplified- The best Video Course by Smart-Investing.in

Check out Industry Peers

Peers & Returns1W1M1Y
CAPLIN POINT LABORATORIES -2.8% 6.4% 29.9%
SUN PHARMACEUTICAL INDUSTRIES -1.6% -4.3% 18.1%
DRREDDYS LABORATORIES 5.7% 15.3% 89.1%
DIVIS LABORATORIES -2.3% -3.3% 101.9%
CIPLA 2% 2.6% 69%
PIRAMAL ENTERPRISES -10.1% -12.6% -29.3%
LUPIN -2.1% 4.5% 37.2%
AUROBINDO PHARMA -3.7% -10.4% 29.5%
TORRENT PHARMACEUTICALS -6.3% -5.2% 62%

FUNDAMENTAL ANALYSIS OF CAPLIN POINT LABORATORIES

Fundamental Score of the company compares the financial strength of the company with it's Industry peers as well as other companies in the stock market.

Fundamental Score is derived based on the statistical analysis of 10+ years historical data for consistency, drift and industry outperformance of underlying attributes listed below:

1. Company size based on Revenues. Learn More
2. Growth based on Net Income . Learn More
3. Profit Margins. Learn More
4. Return on Capital Employed (ROCE). Learn More
5. Debt Ratios. Learn More
6. Return on Invested Capital (ROIC). Learn More
7. Cost of Capital (WACC). Learn More
8. Moat size. Learn More

Please check the Financials tab for more information.
Fundamentals Score
[Last Annual Data : Mar2020 | TTM
Trailing Twelve Months (TTM) is calculated using last 4 quarterly data and is a good substitute to track Annual results.
Learn More
]
Show Me the Stocks with Fundamentals better than CAPLIN POINT LABORATORIES Premium

As on 24-Sep-2020, the Fundamentals of CAPLIN POINT LABORATORIES are Strong and hence it's good for long term investment! See Financial Performance of CAPLIN POINT LABORATORIES . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!


VALUATION OF CAPLIN POINT LABORATORIES

Valuation Score of the company compares the current market value with the intrinsic/fair value of the business as compared to other companies. The fair value has been calculated based on three models:

1. Median Enterprise Value to EBIDTA model calculated over last 12 years data (where available).
Enterprise Value = Market Cap + Debt - Cash. Learn More

2. Median Enterprise Value to Sales model calculated over last 12 years data (where available).
Enterprise Value = Market Cap + Debt - Cash. Learn More

3. Median Price to Sales model calculated over last 12 years data (where available). This model is useful to analyze no profit companies. Learn More

Valuation Score
RatioValue
P/E
P/B
P/S
PEG
29.11
9.98
8.03
-
Show Me the Stocks with Valuation better than CAPLIN POINT LABORATORIES Premium

As on 24-Sep-2020, CAPLIN POINT LABORATORIES is Over Valued and hence NOT a good buying opportunity according to Share Valuation at this time!


INTRINSIC VALUE OF CAPLIN POINT LABORATORIES

This section compares the current market price of the stock with Intrinsic value of the stock calculated based on 3 Valuation models described in the Valuation section.

If Intrinsic Value (Enterprise Value/EBIDTA Model) is -ve, the company made a loss in last financial year or had a high debt.

If Intrinsic Value (Enterprise Value/Sales Model) is -ve, the company had a high debt in the last financial year.

If Intrinsic Value (EV/Sales OR Price/Sales Model) is 0, the latest data is not available.
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
36%
73%
69%

As on 24-Sep-2020, the Intrinsic Value of CAPLIN POINT LABORATORIES is Rs. 319.09 determined based on Median of the 3 historical models.
Intrinsic Value based on Median EV / EBIDTA Model : Rs. 397.36
Intrinsic Value based on Median EV / Sales Model : Rs. 311.68
Intrinsic Value based on Median Price / Sales Model : Rs. 319.09
Median Intrinsic Value of CAPLIN POINT LABORATORIES : Rs. 319.09

As on 24-Sep-2020, CAPLIN POINT LABORATORIES is trading at a Premium of 69% based on the Median Intrinsic Value!


SHARE PRICE MOMENTUM OF CAPLIN POINT LABORATORIES

|    10 Year Share Price Graph

DEBT

Year Debt/Equity ratio
Debt/Equity ratio analysis

For Banking industry,
Good = Ratio less than 13
Average = Ratio between 13 and 15
Bad = Ratio greater than 15

For all non-Banking industries,
Good = Ratio less than 0.4
Average = Ratio between 0.4 and 0.6
Bad = Ratio greater than 0.6

Worst is considered between Standalone & Consolidated
Standalone Consolidated
2019
2018
2017
Avg_3yrs
0
0
0
-
0
0
0
-
[Last Annual Data : Mar2020]

PLEDGED SHARES

Pledged Shares
0 %
As of : July 14,2020

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad

QTRLY RESULTS

Parameter 1 Qtr Growth 4 Qtr Growth
Revenue
Op Profit
EBIDT
Net Income
19.58%
-14.04%
-14.88%
-16.21%
-14.64%
-21.56%
-24.33%
-30.08%
QtrlyTrend
-6
Quarterly Trend analysis

The growth rate score are assigned as under:
If ratio's 1Q growth is +ve, then 1. If -ve, then -1.
If ratio's 4Q growth is +ve, then 1.If -ve, then -1.
Growth Score= Sum of all the above scores for Revenue, Operating Profit and Net Income.

Interpretation
Good = Growth Score >=4
Neutral = Growth Score between 0 and 4
Bad = Growth Score less than 0
Latest Qtr: Jun2020




Open Demat Account & Start Investing
    Affiliate Links

Disclosure

The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].
All Stocks : A - Z
ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z